Illumina Inc (ILMN) reports steady revenue growth and strategic advancements, while addressing competitive pressures and geopolitical risks.

Q4 2024 Management View CEO Jacob Thaysen highlighted the transformative progress Illumina made in 2024, emphasizing its strategic roadmap targeting high single-digit revenue growth by 2027. He noted ...

Some senior partners have been voicing these concerns since late last year, even before Donald Trump was re-elected with a ...

Tariffs of 10 percent on all Chinese imports took effect on Feb. 4, 2025, following President Donald Trump's executive order under the ...

Illumina's (ILMN) stock slid 5% post-market after it released its Q4 earnings report and reiterated its 2025 guidance, ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

China announced it would impose additional tariffs on certain US imports from February 10, 2025 in retaliation to ...

Leading American genomic sequencing firm Illumina says it is evaluating Beijing’s announcement with hope of ‘positive ...

McKinsey and Co., the US multinational strategy and management consultancy, is reportedly questioning its presence in China ...

Chinese regulators have been in discussions with Apple executives and app developers since last year over fee concerns.

New tariffs on China imposed by Trump — and an end to direct e-commerce shipping to U.S. consumers — could impact Shein and Temu, but their influence extends globally.